Reducing Size with a Microfluidizer

2022-05-21 23:20:09 By : Mr. John Wang

We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.

The unit operation of size reduction is usually monitored through particle size analysis. Numerous technologies are available to perform size reduction, homogenization, or both. Microfluidizer is one technology that is used to reduce the size of suspensions and emulsions in an efficient way. In this article, a lab-scale Microfluidizer was used to process an emulsion and liposomes formulation, and a Entegris Nicomp dynamic light scattering (DLS) system was used to study the size reduction process.

Microfluidics’ Microfluidizer was used to process the target samples in this study. The sample present in an inlet reservoir is taken by the Microfluidizer, and an intensifier pump creates pressures of up to 40,000 psi to push the sample via the interaction chamber.

This interaction chamber exposes the sample to strong, continuous impact and high shear rates. Following this, the sample is cooled, and the nanoscale particles are either reclaimed for use or recirculated for numerous passes to obtain the required homogeneous particle size distribution. This Microfluidizer method can be repeated and can be scaled up from lab to commercial processing volumes.

Figure 2. Y single slotted (left) and multi-slotted (right) interaction chambers

All of the samples considered in this study were processed on the bench top unit, LV1 Microfluidizer (Figure 3). This unit was designed to provide milliliter-scale Microfluidizer quality nanotechnology processing, with many uses in the biotechnology, pharmaceutical, and other industries.

A laser diffraction analyzer was used to make the measurements to monitor the size reduction for the before processing results, and a Entegris Nicomp DLS system (Figure 4) was used to make the measurements for the post processing analysis.

Figure 4. The Nicomp DLS system

An oil-in-water emulsion was the initial sample that mimics a drug delivery vehicle. The scattered phase includes 1.5 wt% surfactant and 5 wt% Squalane. The following formula was used to create dispersion:

Before processing on the Microfluidizer, a rotor-stator mixer (IKA T25) was used to mix the sample for a period of 5 minutes. The LV1 Microfluidizer processor was then used to create the nanoemulsions. Using the F12Y chamber operating at 20k psi Sample 329A was processed, and using the F12Y chamber operating at 30k psi Sample 329B was processed. Both samples were processed at the selected pressure for one and five passes via the Microfluidizer. The following formula was used to generate the second sample, liposomes:

Before processing on the Microfluidizer, a rotor-stator mixer (IKA T25) was used to mix the sample for 5 minutes. The LV1 Microfluidizer processor was then used to produce the liposomes. Sample 329C was processed using the F12Y chamber operating at 20k psi, and Sample 329D was processed using the F12Y chamber operating at 30k psi. Both samples were processed at the selected pressure for one, two and five passes via the Microfluidizer.

The nanoemulsion sample was measured after mixing by rotor-stator but before processing by the Microfluidizer by laser diffraction to have a median size (Dv50) = 8.5 μm, or 8500 nm. Using the Microfluidizer, the sample was subsequently processed at 20k psi and finally determined by the Nicomp DLS system following one and five passes. The results are depicted in Figures 5 and 6, and Table 1.

Figure 5 displays the processed results in light blue (right Y axis) and the unprocessed to processed size reduction in orange (left Y axis). Table 1 shows the polydispersity index PI and intensity weighted mean diameter.

Figure 5. Nanoemulsion sample 329A, unprocessed and 1 and 5 passes, 20k psi.

Figure 6. Nanoemulsion sample 329A, 1 and 5 passes, 20k psi.

Table 1. Nanoemulsion sample 329A, 1 and 5 passes, 20k psi

Subsequently, the Microfluidizer was used to process the sample at 30k psi, and the same was determined by the Nicomp DLS system following one and five passes. The results are illustrated in Figures 7 and 8 and Table 2.

Figure 7. Nanoemulsion sample 329B, unprocessed and 1 and 5 passes, 30k psi

Figure 8. Nanoemulsion sample 329B, 1 and 5 passes, 30k psi

Table 2. Nanoemulsion sample 329B, 1 and 5 passes, 30k psi

The rotor-stator mixer was used to mix the liposome sample and the same was measured. However, this was done prior to processing by the Microfluidizer by laser diffraction to possess a median size (Dv50) = 8.9 µm. The Microfluidizer was then used to process the sample 329C at 20k psi and determined by the Nicomp DLS system following one, two, and five passes. The results are displayed in Figures 9 and 10 and Table 3. Figure 8 depicts the processed results in maroon (right Y axis) and the unprocessed to processed size reduction in blue (left Y axis).

Figure 9. Liposome sample 329C, unprocessed, and processed at 1, 2, and 5 passes, 20k psi

Figure 10. Liposome sample 329C, 1, 2, and 5 passes

Table 3. Liposome sample 329C after 1, 2 and 5 passes, 20k psi

Again, the Microfluidizer was used to process the liposome sample 329D at 30k psi and determined by the Nicomp DLS system following one, two, and five passes. The results are depicted in Figures 11 and 12 and Table 4.

Figure 11. Liposome sample 329D, unprocessed, 1, 2, and 5 passes, 30k psi.

Figure 12. Liposome sample 329D, 1, 2, and 5 passes, 30k psi

Table 4. Liposome sample 329D, 1, 2, and 5 passes, 30k psi

This article has shown how the LV1 Microfluidizer is a simple and efficient technology that can be used for producing liposome and nanoemulsion samples. Size distributions turn out to be tighter and smaller after processing via the Microfluidizer. A major advantage of carrying out lab scale processing and formulation experiments is that with the help of the Microfluidizer the process can be ramped up to commercial scale without any major complications or any need for extra development work. The Nicomp DLS system was shown to be a simple and effective instrument for monitoring the size reduction using the Microfluidizer.

This information has been sourced, reviewed and adapted from materials provided by Entegris

For more information on this source, please visit Entegris

Please use one of the following formats to cite this article in your essay, paper or report:

Entegris. (2021, December 03). Reducing Size with a Microfluidizer. AZoM. Retrieved on May 21, 2022 from https://www.azom.com/article.aspx?ArticleID=12998.

Entegris. "Reducing Size with a Microfluidizer". AZoM. 21 May 2022. <https://www.azom.com/article.aspx?ArticleID=12998>.

Entegris. "Reducing Size with a Microfluidizer". AZoM. https://www.azom.com/article.aspx?ArticleID=12998. (accessed May 21, 2022).

Entegris. 2021. Reducing Size with a Microfluidizer. AZoM, viewed 21 May 2022, https://www.azom.com/article.aspx?ArticleID=12998.

Thank you for good explanation about microfluidizer method in particle production. Is this equipment could be used for emulsion which made by solid lipid?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoM.com.

Do you have a question you'd like to ask regarding this article?

AZoM speaks with Dr. Nicola Ferralis from MIT about his research that has developed a low-cost process of creating carbon fibers from hydrocarbon pitch. This research could lead to the large-scale use of carbon fiber composites in industries that have thus far been limited.

In this interview, AZoM speaks with Marco Enger, Senior Tribologist from GGB, to discuss how nano fillers affect transfer films within tribological systems.

Ahead of their talk on green chemistry and profitability in laboratory research at ChemUK 2022, AZoM spoke with Jacqueline Balian from Gambica and Martyn Fordman from Asynt about encouraging sustainability in the chemical industry.

COXEM's CP-8000+ is a powerful cross section polishing tool that uses an argon ion beam to allow precise, advanced sample preparation. Its state-of-the-art technology means the sample is not deformed and does not suffer any kind of physical damage.

This product profile outlines the background information of ARSST tool that is being used for screening tests and operating in "open cell" mode.

This product profile outlines the Evolution™ Pro UV-Vis Spectrophotometers from Thermo Fisher Scientific.

AZoM.com - An AZoNetwork Site

Owned and operated by AZoNetwork, © 2000-2022